Turn Therapeutics Inc (TTRX)

Jan 01, 2026

Ceapro (OTCMKTS:CRPOF) vs. Turn Therapeutics (NASDAQ:TTRX) Head to Head Review - Defense World

Jan 01, 2026

Jan 01, 2026

Turn Therapeutics (NASDAQ:TTRX) Upgraded at D Boral Capital - Defense World

Jan 01, 2026

Dec 30, 2025

Turn Therapeutics (NASDAQ:TTRX) Now Covered by Analysts at D. Boral Capital - Defense World

Dec 30, 2025

Dec 29, 2025

TTRX Analyst Forecasts - Quiver Quantitative

Dec 29, 2025

Dec 29, 2025

Turn Therapeutics Inc. Common Stock (TTRX) Stock News & Articles - 24/7 Wall St.

Dec 29, 2025

Dec 29, 2025

D. Boral Capital initiates Turn Therapeutics stock with Buy rating By Investing.com - Investing.com Canada

Dec 29, 2025

Dec 27, 2025

What date does Turn Therapeutics Inc.'s (TTRX) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

Dec 27, 2025

Dec 24, 2025

Death Cross: Is Beam Therapeutics Inc. stock a defensive play in 2025Exit Point & Safe Entry Zone Identification - moha.gov.vn

Dec 24, 2025

Dec 23, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 23, 2025

Dec 22, 2025

Will Tempest Therapeutics Inc. stock beat EPS estimatesJuly 2025 Weekly Recap & Weekly High Potential Stock Alerts - bolumsonucanavari.com

Dec 22, 2025

Dec 21, 2025

Portfolio Shifts: Is Enliven Therapeutics Inc. stock near bottom after decline2025 Volatility Report & Daily Entry Point Trade Alerts - moha.gov.vn

Dec 21, 2025

Dec 21, 2025

Will Whitehawk Therapeutics Inc. stock recover faster than market2025 Earnings Surprises & Detailed Earnings Play Alerts - Улправда

Dec 21, 2025

Dec 20, 2025

Can Karyopharm Therapeutics Inc. stock resist sector downturnsJuly 2025 Market Mood & High Accuracy Trade Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

Why MiNK Therapeutics Inc. stock attracts global investors2025 Market Trends & Short-Term High Return Ideas - Улправда

Dec 20, 2025

Dec 20, 2025

Is Foghorn Therapeutics Inc. stock resilient to inflation2025 Support & Resistance & Real-Time Chart Breakout Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

Why Anika Therapeutics Inc. stock remains on watchlistsMarket Activity Report & Community Trade Idea Sharing - Улправда

Dec 20, 2025

Dec 19, 2025

Will Neumora Therapeutics Inc. stock benefit from AI adoptionOil Prices & Weekly Setup with High ROI Potential - Улправда

Dec 19, 2025

Dec 19, 2025

Loss Report: Can Xilio Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 EndofMonth & High Win Rate Trade Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Will Intensity Therapeutics Inc. stock split attract more investorsJuly 2025 News Drivers & AI Based Buy and Sell Signals - Улправда

Dec 19, 2025

Dec 19, 2025

How geopolitical tensions affect Spyre Therapeutics Inc. stock2025 Historical Comparison & Real-Time Volume Trigger Notifications - ulpravda.ru

Dec 19, 2025

Dec 19, 2025

Is Cidara Therapeutics Inc. stock a top momentum playMarket Activity Report & AI Enhanced Trade Execution Alerts - Улправда

Dec 19, 2025

Dec 19, 2025

Is Beam Therapeutics Inc. stock cheap compared to fundamentalsMarket Growth Report & Short-Term High Return Strategies - Улправда

Dec 19, 2025

Dec 18, 2025

Is Aquestive Therapeutics Inc. stock positioned for digital transformation2025 Key Highlights & Expert Approved Trade Ideas - Улправда

Dec 18, 2025

Dec 18, 2025

Will Tempest Therapeutics Inc. stock split again soonJuly 2025 Earnings & Accurate Intraday Trading Signals - Улправда

Dec 18, 2025

Dec 18, 2025

How Marker Therapeutics Inc. (GX1) stock reacts to new regulationsJuly 2025 Earnings & Low Volatility Stock Recommendations - Улправда

Dec 18, 2025

Dec 18, 2025

Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда

Dec 18, 2025

Dec 15, 2025

Turn Therapeutics Inc. (TTRX) - Zacks Investment Research

Dec 15, 2025

Dec 12, 2025

CFO Chaudhary Buys 2,500 ($8.8K) Of Turn Therapeutics Inc [TTRX] - TradingView — Track All Markets

Dec 12, 2025

Dec 05, 2025

Can Black Diamond Therapeutics (BDTX) Turn Silevertinib’s Dual-Cancer Ambition Into a Cohesive Strategy? - Yahoo Finance

Dec 05, 2025

Nov 28, 2025

Is CytomX Therapeutics Inc. (6C1) stock attractive for dividend growthJuly 2025 Snapshot & Technical Pattern Based Buy Signals - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Why Intensity Therapeutics Inc. stock appeals to analystsQuarterly Portfolio Review & Free Risk Controlled Daily Trade Plans - moha.gov.vn

Nov 28, 2025

Nov 28, 2025

Volatility Watch: Why Seres Therapeutics Inc. stock is rated strong buyJuly 2025 Review & High Accuracy Trade Alerts - moha.gov.vn

Nov 28, 2025

Nov 25, 2025

Arthur Golden Increases Stake in Turn Therapeutics Inc with Rece - GuruFocus

Nov 25, 2025

Nov 25, 2025

Golden Arthur F buys Turn Therapeutics shares worth $33945 By Investing.com - Investing.com Nigeria

Nov 25, 2025

Nov 25, 2025

Golden Arthur F buys Turn Therapeutics shares worth $33945 - Investing.com

Nov 25, 2025

Nov 25, 2025

Turn Therapeutics Director Arthur F Golden Acquires 9,868 Shares - TradingView

Nov 25, 2025

Nov 25, 2025

Dir Golden Buys 9,868 ($33.9K) Of Turn Therapeutics Inc [TTRX] - TradingView

Nov 25, 2025

Nov 24, 2025

Insider Buying: Arthur Golden Acquires Additional Shares of Turn Therapeutics Inc (TTRX) - GuruFocus

Nov 24, 2025

Nov 24, 2025

Turn Therapeutics Director Arthur F. Golden Acquires 20,532 Shares - TradingView

Nov 24, 2025

Nov 24, 2025

Dir Golden Buys 20,532 ($58.9K) Of Turn Therapeutics Inc [TTRX] - TradingView

Nov 24, 2025

Nov 24, 2025

[Form 4] Turn Therapeutics Inc. Insider Trading Activity - Stock Titan

Nov 24, 2025

Nov 24, 2025

Turn Therapeutics Inc. Common Stock trading resumes - MSN

Nov 24, 2025

Nov 18, 2025

Zuraiz Chaudhary buys Turn Therapeutics (TTRX) shares worth $9,050 By Investing.com - Investing.com Nigeria

Nov 18, 2025

Nov 17, 2025

Zuraiz Chaudhary buys Turn Therapeutics (TTRX) shares worth $9,050 - Investing.com

Nov 17, 2025

Nov 15, 2025

Turn Therapeutics (TTRX) FDA Approvals, PDUFA Dates & Drug Alerts 2025 - MarketBeat

Nov 15, 2025

Nov 14, 2025

Turn Therapeutics’ GX-03 Recognized for Dermatology Innovation - MSN

Nov 14, 2025

Nov 13, 2025

Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates - The Manila Times

Nov 13, 2025

Nov 12, 2025

Turn Therapeutics GX-03 Technology Named as One of Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment by Patient Care Online Magazine - MarketScreener

Nov 12, 2025

Nov 11, 2025

Turn Therapeutics (Nasdaq: TTRX) features Dr. Robert Redfield on trust in science - Stock Titan

Nov 11, 2025

Nov 11, 2025

Turn Therapeutics’ GX-03 Technology Named as One of 'Five Novel Mechanisms Reshaping Atopic Dermatitis Treatment” by Patient Care Online Magazine - The Manila Times

Nov 11, 2025

Nov 11, 2025

Turn (NASDAQ: TTRX) named among five novel eczema mechanisms by Patient Care Online - Stock Titan

Nov 11, 2025

Nov 11, 2025

Turn Therapeutics CEO, Bradley Burnam, Speaks with Former - GlobeNewswire

Nov 11, 2025

Nov 05, 2025

Turn Therapeutics appoints Andrew Scott as VP of Corporate Communications - Investing.com Australia

Nov 05, 2025

Nov 05, 2025

Turn Therapeutics Appoints Veteran Capital Markets Executive Andrew Scott as Vice President of Corporate Communications - The Manila Times

Nov 05, 2025